3 days of unmissable content covering key challenges from R&D, CMC, manufacturing, supply chain, process development and analytics
2 revitalized workshop sessions to take part in intimate discussions with KOLs from Poseida Therapeutics and CytoImmune Therapeutics
20+ hours of dedicated sessions covering the end-to-end scope of donor selection, screening, characterizing and making critical decisions to guarantee commercialization and marketing access
Having issues downloading? Click here
Previously Attending Companies Include
